Top Markets
Coin of the day
AEON Biopharma, Inc. AEON Biopharma, Inc.

AEON Biopharma, Inc.

AEON
Rank in Stocks #31959
AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in... AEON Biopharma, Inc. is a biopharmaceutical company primarily engaged in developing therapies based on botulinum toxins, aimed at treating various debilitating medical conditions. Among its key investigational products is ABP-450, a 900 kDa botulinum toxin complex, which is being advanced for therapeutic use in conditions such as migraine, cervical dystonia, and gastroparesis. The entity, originally known as ALPHAEON Corporation, adopted the name AEON Biopharma, Inc. in December 2019. Established in 2012, the company maintains its principal operations from Newport Beach, California.
Share Price
$0.262
Last synced: 2026-08-17
Market Cap
$11.57M
Change (1 day)
-5.00%
Change (1 year)
-65.30%
Country
US
Trade AEON Biopharma, Inc. (AEON)

Category

EPS for AEON Biopharma, Inc. (AEON)
EPS as of 2026 TTM: 0
According to AEON Biopharma, Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for AEON Biopharma, Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors